Indication
ALI
9 clinical trials
11 products
1 drug
Clinical trial
A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Subjects Undergoing Surgery for Congenital Heart DefectsStatus: Completed, Estimated PCD: 2019-06-01
Product
L-citrullineClinical trial
Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung InjuryStatus: Terminated, Estimated PCD: 2021-12-31
Product
HeparinClinical trial
Effects of Hyperoxia Induced Pulmonary Inflammation and Organ Injury in a Human in Vivo ModelStatus: Recruiting, Estimated PCD: 2024-12-30
Product
Liquid oxygenProduct
Medical airProduct
Sodium-chlorideClinical trial
Pirfenidone Versus Placebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following Hypofractionated Radiotherapy in Breast Cancer Patients (PRILI): A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study EvaluatingStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Pirfenidone/PlaceboClinical trial
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory FailureStatus: Completed, Estimated PCD: 2021-02-22
Product
AviptadilProduct
Normal SalineClinical trial
Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung InjuryStatus: Completed, Estimated PCD: 2021-07-16
Product
Ascorbic AcidDrug
VarlilumabClinical trial
Inhaled ZYESAMI (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-3)Status: Withdrawn, Estimated PCD: 2022-06-15
Product
ZYESAMIClinical trial
Inhaled ZYESAMI™ for the Treatment of Severe COVID-19Status: Terminated, Estimated PCD: 2021-12-15
Clinical trial
A Phase 2b Open-Label, Single Arm Study to Evaluate the Efficacy of Voxelotor for Improving Oxygen Saturation and Reducing Ventilatory Support Requirements in Adult Patients With New or Increased Oxygen RequirementStatus: Terminated, Estimated PCD: 2023-06-28
Product
Voxelotor